Newbury Pharmaceuticals AB (NEWBRY) — Net Asset Momentum
Newbury Pharmaceuticals AB (NEWBRY) recorded a net asset momentum of 5.1% as of August 2024, with net assets of Skr51.92 Million SEK. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See Newbury Pharmaceuticals AB defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
Newbury Pharmaceuticals AB Net Asset Momentum (2021–2024)
This chart tracks Newbury Pharmaceuticals AB's year-over-year net asset growth across 4 annual reporting periods from 2021 to 2024. The most recent momentum reading is +5.1%, with net assets of Skr51.92 Million SEK as of August 2024. Read debt load of Newbury Pharmaceuticals AB for a breakdown of total debt and financial obligations.
Annual Net Asset History for Newbury Pharmaceuticals AB (2021–2024)
The table below shows the complete annual net asset history for Newbury Pharmaceuticals AB from 2021 to 2024, covering 4 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see NEWBRY market cap overview.
| Year | Net Assets (SEK) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | Skr51.92 Million | Skr90.87 Million | Skr38.95 Million | ▲ +5.1% |
| 2023 | Skr49.38 Million | Skr72.92 Million | Skr23.54 Million | ▼ -28.2% |
| 2022 | Skr68.77 Million | Skr86.91 Million | Skr18.14 Million | ▲ +78.8% |
| 2021 | Skr38.47 Million | Skr42.81 Million | Skr4.34 Million | — |